
TSE:SIS
This summary was created by AI, based on 5 opinions in the last 12 months.
Savaria Corp (SIS-T) has garnered attention from various experts who highlight its resilience after facing challenges from tariffs last year. The company's pivot towards a focus on Europe and positive growth trajectories are viewed favorably. Analysts note that Savaria is well-positioned in the accessibility industry, catering to the aging population's desire to age at home gracefully. The company's product offerings are primarily CUSMA-compliant and many are exempt from tariffs due to FDA regulations, ensuring a competitive edge. With a long-term growth outlook supported by cost-cutting measures and new products, the consensus suggests that owning this stock could be beneficial as it aims for continued expansion over time.
They had an earnings release recently that the market didn't like. Still a growth story. Well diversified internationally. Good insider participation. Demographic story on baby boomers needing accessibility aids. Trading at a cheaper valuation than I had been trading for a while. (Analysts’ price target is $18.75)